Slow Bull
The market, slowly. SATURDAY, 26 SEPTEMBER 2026

IM Cannabis Corp.

IMCC Nasdaq SEC CIK 1792030
Follow IM Cannabis Corp. Weekly email: filings, results, news

Financials

Reported figures only · latest: Q4 2025 CAD · IFRS
EPS, diluted -
Revenue by quarter
CAD 14.8M
CAD 12.7M
Q2 24 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−CAD 200M−CAD 100MCAD 0CAD 100MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25CAD 54.7M−CAD 11.3M
FY24CAD 54M−CAD 10.6M
FY23CAD 48.8M−CAD 9.5M
FY22CAD 54.3M−CAD 188.9M
FY21CAD 34.1M−CAD 17.8M
FY20CAD 15.9M−CAD 28.7M
FY19CAD 9.1M−CAD 7.3M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−400%−200%0%200%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2517.7%−21.2%−20.7%
FY2415.6%−18.9%−19.6%
FY2320.2%−26.2%−19.5%
FY2216.9%−56.7%−347.6%
FY2118.6%−67.6%−52.2%
FY2065.9%−51.9%−180.6%
FY1943.3%−113.2%−80.4%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−CAD 40M−CAD 20MCAD 0CAD 20MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25CAD 4.7M
FY24−CAD 1.2M
FY23−CAD 8.7M
FY22−CAD 14.2M
FY21−CAD 39M
FY20−CAD 10.5M
FY19−CAD 7.5M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • IM Cannabis Corp.
  • Healthcare median
−400%−300%−200%−100%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearIM Cannabis Corp.Healthcare median
FY25−20.7%−66.4%
FY24−19.6%−87%
FY23−19.5%−128.5%
FY22−347.6%−143.6%
FY21−52.2%−137.7%
FY20−180.6%−134.3%
FY19−80.4%−125.9%
FY18-−172.7%

News

No stories filed under IM Cannabis Corp. yet - coverage appears here as the news feed clusters it.